According to the report by CNET, the tech website has contacted NPD DisplaySearch analyst Paul Semenza and he states, "We expect panel production to start in August, with production ramping up to high volumes (more than a million units per month) in the fourth quarter."
The report goes on to state, "Semenza said this is DisplaySearch's "understanding of the activity for the 7.85 [inch] panel expected to be used in the iPad Mini. If this production schedule plays out, it could indicate a late 2012 launch", he said."
If this report is true then we could see the tablet launched before the year ends. This report falls in line with another report that surfaced a few days ago, which indicated that Apple would host a special event for the iPad mini.
A few days ago, news started doing the rounds claiming that the iPad mini will launch at the same time as the next iPhone. However, Apple would likely intend to keep the spotlight fixed on the next iPhone aka the iPhone 5 as it will be nearly a year since they launched the iPhone 4S and are now facing increased competition from the likes of Samsung.
Samsung have successfully launched the Galaxy S III and have recorded over 10 million units sold. The brand also intends to unveil the Galaxy Note 2, a successor to the Galaxy Note by the end of August.
This would certainly put pressure on Apple as they usually launch just a single smartphone in a calendar year. Samsung has a whole line up of devices that aim to compete with the iPhone and if Apple does launch the iPad mini at the same time, it will take some of the shine off the iPhone 5, which it definitely does need.
The iPad mini is expected to feature a display of 7.85-inches and will compete directly against the Google Nexus 7, the 7-inch flagship Google tablet which is doing really well in the market.
This smaller iPad is also expected to feature a smaller dock connector and a microphone at the back. The microphone on the rear will assist the device in noise cancellation during video calls that can be done using Apple’s FaceTime or through Skype.
As erotic movie Jism 2 has not released yet and there is a lot of buzz about a porn star Sunny Leone and her bold erotic uncensored scenes. Youth are awaiting to watch bold,hot and sexy porn star Sunny Leone in Pooja Bhatt's 'Jism 2' but the actress-turned-director has started working on the third film in 'Jism' franchise, with plans to make it in 3D.
"I had my script ready a long time back. I want to get it out of my system. I will make 'Jism 3' in 3D. It will be interesting to make an erotic film in 3D," Pooja told IANS."In fact we had plans to make 'Jism 2' in 3D. But later we felt it would look very ahead of times," she added.
Indo-Brazilian Nathalia Kaur to lead in "Jism 3", may be Indo-canadian star Sunny Leone hasn't deliver the best in Jism 2
Ram Gopal Varma's discovery Nathalia Kaur will now be seen in Pooja Bhatt's next directorial venture 'Jism 3'. While 'Jism' had Bipasha Basu in a sizzling hot avatar, the just released second installment saw adult star Sunny Leone. 'Jism 3' will have not one but two actresses and Nathalia will be one of them.Incidentally, Pooja shot with Nathalia for the poster of the Sunny Leone-Randeep Hooda starrer. "When it was revealed that it was Nathalia who shot for the poster, Mahesh Bhatt saab texted me about casting her in the next installment. You just can't ignore his suggestions."
Asked if Sunny, too, will feature in 'Jism 3', Pooja says, "It is too early to tell. When I was making the second film, everyone asked if Bipasha would be in it and now everyone is asking if Sunny will be in the next.
Who is Nathalia Kaur?
Nathalia Kaur, also known as Nathalia Pinheiro, is an Indian Brazilian Model, Bollywood actress and a trained Opera singer
Nathalia Kaur was crowned as the Kingfisher Calendar Girl at 2012. She made her debut in the Kannada film Dev Son of Mudde Gowda directed by Indrajit Lankesh. Before her first film was released she was chosen by popular Bollywood director Ram Gopal Varma to do an item song Dan Danfor his next film. Earlier Sunny Leone was to do the song but due to her contract for the film Jism 2, Varma replaced her with Kaur. Ram Gopal Varma, who was always admitted himself to be an admirer of the beauty of a woman was overwhelmed by the actress and said that he had never seen a woman more beautiful than Nathalia in his entire life, not only his career. It is said that Ram Gopal Varma cast her as the heroine for his next film called Andam along with Rana Daggubati.
(IANS, Mid-Day, www.nathaliakaur.com)
Bollywood actor Uday Chopra is all set to launch a new label of comic books, 'Yomics', based on Yash Raj movies like 'Dhoom' and 'Ek Tha Tiger'. The actor says that it is his passion for comics and graphic novels which has led him to embark on this endeavour.
"I love reading comics and it's my passion. Most people don't want to get into this (comics) because they don't want to put money into it. But I feel if I am able to create an industry which doesn't exist today, I will be the one to start it. But more than that, it is the love for comics which has led me to this," he said at the launch of 'Yomics' at Yash Raj Studios Tuesday.
 |
| Ek tha tiger from yomics.in |
There are four titles which are ready as of now; 'Dhoom', 'Ek Tha Tiger', 'Hum Tum' and a new character based comic called Daya Prochu. The actor says that the fifth title is in the pipeline and will be introduced during Diwali.
"Every month a new 'Yomic' will come. We will be adding the fifth title during Diwali. The new title is very different to 'Dhoom' and 'Ek tha tiger'. I want to give the readers something completely new," he said.
Daya Prochu is an original addition by Uday Chopra. He is shown to be a fun school-going boy and Chopra feels that everyone will be able to relate to him.
"Daya is a school child and his thoughts are different. We all have a Daya Prochu in us. We have all been bullied, but his character bullies other people. It's a fun character," he added.
Talking about the impact of his venture, Chopra says that it purely depends on how the audience accept this medium. He is introducing four titles together in the hope that different people will associate to and like different characters and will like to read more about them.
"The success of any skill depends on the audience. I am bringing out four titles together so that they might like at least one. They might identify with at least one character and people will like to read their stories. I will keep at it for a while," he added.
Chopra said his 'Yomics' are very different to conventional comic books which are available. Their look and feel makes them distinct.
"I have kept the art work very colourful and simple. It is not grim. Today's comics are very grim and dark. I want to stay away from that. I want to cater to a universal audience and make them feel happy about it. I will enter that realm also but right now I want to make them very appealing," he said.
The Yash Raj banner is known for its love sagas and these surely will not be kept out of their comic books. Chopra plans to introduce them eventually.
"I have thought about it. I don't know how they will do in a comic book format. This format needs action to get moving. But in the west they don't only have action comic books and I don't see any reason for not doing that here. We will love to do it in a while," he added
Hidden Gem: Lincoln Pharmaceuticals Ltd Currently trading at Rs 27/ - EPS 4/- Target 45/- & 65/-
Buy Lincoln Pharmaceuticals Ltd at 27/- EPS 4/- Target 45/- & 65/-
Lincoln Pharmaceuticals Ltd. is another Natco Pharma Ltd (NATCO Pharma Ltd was recommended NATCO at 45/- 3 years back Now 357/- and touched 435/- means 10 times in 3 years; Like Natco Pharma Lincoln Pharma also move in Short term and Medium term TO 65/- & 150/-.)
Buy in for your Portfolio and get good returns in short term.
USFDA Approval News coming soon; its good Value Buy at this rate 27/- to 28/-.
Lincoln Pharmaceuticals Ltd Having Valuable Land in Ahmadabad nearly 7 Acres Value is nearly 21 Cr. Equity is just 11 Cr.
BUY LINCOLN PHARMACEUTICALS Ltd; doing Pharma Business; Stock Trading in BSE (Code : 531633) only . EPS 4/- Book Value 49/- PE just 7, Pharma Industry Avarage PE was 17; But this stock trading with PE just 7; If we take low PE 10 it will go 45/- ++; Equity 11 Cr; Every Year Dividend giving company from last 5 years onwards 12% means Rs. 1.2/- per share. Promoters Holding 39.78% Corporate Bodies 12.4% Public only 40% Target 65/- & 85/- within Short time.
Market may touch NIFTY 5,350 and BSE Sensex 17,500 SOON; FII's are hevily buying stage. Use this correction time for Buy LINCOLN PHARMACEUTICALS Ltd at 27/- Just Buy and hold 10 DAYS with good appreciation at 50% Profit because company having USFDA Approval Announcement and good EPS 4/- and good Book value at 49/- Good Dividend Paying company and company having strong fundamentals .
Recently Company allotted Preferential shares at 50/- So this stock is very valuable stock with risk free investment at 27/- . EPS 4/- Book value 49/- and Good Dividend paying Company.
Good Valuable Buy LINCOLN PHARMACEUTICALS Ltd. 10/- face Value Trading at 27/- with Target of 45/-. Risk is very very less because company stock was very Valuable because Book value at 49/ and Expecting EPS 6/- for 2012-2013. In Pharma sector average PE was 17, if you take this 17 Stock will come 90/- If u take minimum PE 10 It will come 65/- Equity 11cr. Just Buy and hold 1 month to 6 months with good appreciation at 100% Profit.
Lot of Accumulation is going on in BSE by Company circle people and operators Because Company engaged in Pharma and stock has good valuable at 31/- and less Equity 11 cr. Good Dividend Paying company. Check Delivery everyday 90% above.
LINCOLN PHARMACEUTICALS Ltd recorded total Revenues of 177 Crores and Net Profit 4.91 Cr for the year 2011-12 asn Expecting Revenue for 2012-13 is 230 Cr and net profit is 6.9 Cr based on this EPS will 6/- above because Expansion Income will add this year.
No Pharma Dividend Paying Company is trading in BSE or NSE with PE 6. Because Avarage PE fort Pharma is 17. But this Lincoln Pharma trading at 6 PE with EPS 4/- this year. Its very good future for this stock, No risk at 27/- Just Buy at 27/- Soon will touch 65/- & 75/-. Preferential Shares also given at 50/- recently. Its come Another NATCO PHARMA soonl NATCO I have Recommended at 45/- 3 years back now 357/- after tocuh 445/- measn 10 times return in 3 years, Same like NATCO this Lincoln Pharma will raise soon…
Share Holding:-
The Promoters holding 39.78%, Corporate bodies hold 12.4%, and Public only 40% .
Lincoln Pharmaceuticals is amongst the top world class quality oriented pharmaceutical producers, manufacturing and marketing various therapeutic molecules under WHO-GMP guidelines.Lincoln Pharmaceuticals Limited has pledged to serve the Health care segments, by providing Quality Pharmaceuticals at affordable prices.
Indian Pharmaceutical Industry is growing fast as far as export market is concerned, During last five years, there is a tremendous growth in the pharmaceutical industry. Lincoln Pharmaceuticals Limited has made successful achievement in overseas network for its formulations.
Lincoln Pharmaceuticals Ltd. has obtained drug registration for about 100 of its pharmaceuticals formulations in more than 10 African as well as in other countries too.
Kenya, Tanzania, Zimbabwe, Nigeria, Uganda, Sri Lanka, United Kingdom, Zambia, Republic of Yemen, Mauritius, Thailand, Ethiopia, Ghana.
Company View International Products
Company future planning is to expand business in following areas. We invite the interested parties from following countries who can represent our company and can explore business.
Carribean Islands,Central America,Latin America
Company plant facilities is certified by WHO GMP authorities as well as by ISO 9002. Company manufacture neutral label products for International Pharma Marketing companies. Company invite companies for contract manufacturing to produce their products.
See calls earned 50% to 300% for the Short term.
1) SE Investments given at 170/- Reached at 375/-
2) Techtran Poly given at 13/- Reached 21/-
3) Suraj Diamonds Given at 38/- reached 55/-
4) Bihar Tubes given at 57/- Reached at 105/-
5) Ponni Sugars given at 55/- Reached 175/-;
6) Pitti Laminations at 39/- Touched 99/-
7) Venus Power given at 8/- Reached 25/-
8) Comp-U-Learn given at 10/- reached 21/-
9) Natco Pharma given at 45/- Reached 445/-
10) Granules India given at 65/- Reached 150/- in very short Period.
11) IDL Industries given at 65/- Reached 99/-
12) Lanco Infra given at 10/- Reached 24/- But now 13/- Every down side at 10/- buy and hold.
13) Vikas WSP given at 15/- Reached 67/-
14) Usher Agro given at 27/- reached 115/-
Positive Points for this stock for Up moving:
1) Company is in Pharma Business; company Circle people and Operators are accumulating at current price. Because Company Stock Good Value at 27/- EPS 4/- PE 6 and Book Value at 49/- Equity is very small at 11Cr promoters Holding 39.78%
2) In Pharma Stocks Average PE was 17 But this stock trading with PE 6; If you take minimum 10 PE it will go 45/- minimum.
3) 12% Dividend Paying Company; September 19th is the Book Closure for Dividend.
4) Small Equity with good promoters Holding and having lot of Reserves and Good Book Value.
5) Lincoln Pharmaceuticals Ltd Having Valuable Land in Ahmadabad nearly 7 Acres Value is nearly 21 Cr. Equity is just 11 Cr.
6) USFDA Approval Announcement by next week.
7) Company having lot of Expansion Plans.
8) For this year Expected Revenue 230 Cr and Net Profit 6.9 Cr EPS 6.5/- PE 4.
9) Company Having good land bank near to Ahmedabad.
Happy Invest ……….. Good Fundamentals and will give good returns from 100% to 300% returns with short and medium terms and Long terms.
The 27-year-old is said to be currently dating singer John Mayer, reported Sun Online.
“I obviously have a lot to say right now. I’m a woman who likes to be courted— strongly. Never say never, I guess you’d say. I’ll let love take the lead on that,” she said.
The star hinted that while she is hailed as the candy princess, she will eventually have to hand over her tiara and move on to something new.
“I love what I do, and when I don’t love what I do, I’ll make a change, I can’t be the candy queen forever,” Perry said.
The singer also said she has no regrets in life and she doesn’t stress about the fact that she is a role model to many.
“I have no regrets. I’m not going to be everything to everyone. I can’t tell a person when it’s time for them to have sex. Or if they should have a cigarette. But I try to live my life with a lot of integrity, and, hopefully, that sends a message.”
( PTI )
Designed to address the problems women face in their private parts, Clean and Dry Intimate Wash offers protection, fairness and freshness. To be used while showering, its special pH-balanced formula cleans and protects the affected area, and even makes the skin fairer. Life for women will now be fresher, cleaner, fairer!
Our fairness obsession – at least in ad campaigns – now borders the ridiculous.
The fairer sex is now required to be literally so: fairer all over, all the time, from our pretty white brow to our bleached little toe, be it in the boardroom or the bedroom. The campaign to eliminate the scourge of darkness has extended to every nook and cranny of a woman’s body. A tiny little tan line? Perish the thought, says Anushka Sharma, as she flaunts her pristinely white finger. Tanned legs from playing tennis? Oh, the horror! As for the female underarm – long tortured and bruised by repeated waxing – the required hue is now a dazzling white once reserved for toilets and sports uniforms.
With women – socialised to fret over their appearance – the Fear Factor always works better. Reuters
So it was only a matter of time before we breached the final frontier: our long-neglectedyonis. Begone nasty purples, reds, and dark (Eeks, there is that word again!) pinks, cried the douche fairy. Let there be white, instead!
Do I think it’s dumb? Sure. For starters, none of the usual rationale of fairness product ads work here. While white is indeed right in the marriage market, this is one virtue that is difficult to list in that matrimonial ad: Khatri girl, 5’3″, convent education, working in MNC, slim, fair everywhere! And flashing your prospective employers is certainly not going to help you land that fancy, corporate job.
As for the bedroom, if a guy (or girl, if that’s the way you swing) is actually looking at your vagina, I can safely promise you, he’s not concerned with its exact hue. And if he is — brace yourself! — the boy’s most likely gay. The Indian male criteria for nookie is pretty straight-forward. He’s virtuously colour-blind if a) you’re pretty; or b) have big tits; or c) if you’re willing put out — in which case, he absolutely, incontrovertibly doesn’t give a damn!
So why bother with a fair and lovely douche?
Ask an advertising honcho like Alyque Padamsee, and you’ll likely get some version of this bit of received wisdom:
It is hard to deny that fairness creams often get social commentators and activists all worked up. What they should do is take a deep breath and think again. Lipstick is used to make your lips redder, fairness cream is used to make you fairer—so what’s the problem? I don’t think any Youngistani today thinks the British Raj/White man is superior to us Brown folk. That’s all 1947 thinking!
( Firstpost )
Sunny Leone says No to Big Boss
It was her big ticket to Bollywood - but Indo-Canadian porn star Sunny Leone says she would never go back to the 'Bigg Boss' house. Sunny told IANS: "I would never go back to the house again...it is insane, it is crazy. But what it did for me is it opened the doors, opened a new world - something that I had never imagined."
The actress is foraying into Bollywood with 'Jism 2', which was offered to her by Mahesh Bhatt while she was in the "Big Boss" house.
"Bhatt saab came in the house and talked about doing a movie, this idea never crossed my mind. I thought I will exit the house and never come back to India... but complete opposite thing happened," she added.
Sunny says the reality shows in West are completely different from what we see in India. "If you compare the reality shows here to there (US), here those who come on the show become very popular and achieve huge success.
"In America, if you do a reality show, they don't care. They don't identify people when they walk on streets, but here it does happen like that," explained the 31-year-old.
Releasing Aug 3, 'Jism 2' has been directed by Pooja Bhatt and Sunny will be seen romancing Arunoday Singh and Randeep Hooda in it. ( IANS )
New hot erotic "Hey Walla" song from Jism 2
Sunny Leone asked for Randeep, Arunoday's medical reports
The actress apparently demanded to see medical certificates of her co-stars Randeep Hooda and Arunoday Singh before agreeing to shoot intimate scenes with them.
Ever since Sunny Leone signed the dotted lines for Pooja Bhatt's upcoming film co-starring Randeep Hooda and Arunoday Singh, she has consistently made headlines.
This will be her first Bollywood film, and buzz is that before shooting for the project, Sunny put a condition in front of Pooja. Apparently, the adult film actress demanded to see medical certificates of both her co-stars.
A source close to the film says, "Before Sunny was to join the cast and crew to shoot her portions, she sent an e-mail to Pooja demanding a medical certificate of Randeep and Arunoday with whom she was scheduled to shoot lovemaking sequences. In all fairness she also sent her own medical certificate. Basically, she wanted to make sure that she was not going to shoot with anyone who had any life threatening disease (Read HIV)."
The source explains, "Pooja Bhatt then told her that this was not the norm in Bollywood unlike for the adult films that Sunny does. The director also explained to her that she would not require to film sequences that she normally shoots for her adult films."
Finally, apparently no such medical certificate was shown to Sunny. The source states, "No one is aware what exactly happened and how Pooja convinced her." We wonder what Randeep and Arunoday had to say about this surprising demand. Pooja Bhatt remained unavailable for comment. (Mid -Day)
Porn Star Sunny Leone's Lingerie to be auctioned..
Director of 'Jism 2' Pooja Bhatt has decided to auction her lead cast's clothes, including undergarments for charity. Makers of the film lately tweeted "@Jism2 Sunny Leone's lingerie along with other clothes of her and other actors up for auction for charity... any takers?"
Porn star Sunny Leone will make her Bollywood debut with 'Jism 2'. Bollywood actors Randeep Hooda and Arunoday Singh will be seen sharing screen space with Sunny in the film. During an interview lately, Pooja Bhatt said that she is auctioning Sunny, Randeep and Arunoday’s entire wardrobe, including their underwear.
Sunny Leone was chosen for the film while she came to India to participate in a popular reality show 'Bigg Boss 5'. Since then, there has been no looking back for the stunning lady.
Pooja Bhatt can't wait to release her film. Instead of August 3, 'Jism 2' will now be released on July 27, 2012. 'Jism 2', a sequel to 2003 film 'Jism', will see Sunny as seductress Izna.
The first song from Sunny Leone, Randeep Hooda and Arunoday Singh starrer 'Jism 2' is out now. As the censor board gave an 'A' rating to the video, director Pooja Bhatt decided to release it on the internet. 'Jism 2' is one of the most awaited films of 2012 as it marks the debut of porn star Sunny Leone in Bollywood.
Ever since Sunny Leone signed the dotted lines for Pooja Bhatt's upcoming film co-starring Randeep Hooda and Arunoday Singh, she has consistently made headlines.
This will be her first Bollywood film, and buzz is that before shooting for the project, Sunny put a condition in front of Pooja. Apparently, the adult film actress demanded to see medical certificates of both her co-stars.
A source close to the film says, "Before Sunny was to join the cast and crew to shoot her portions, she sent an e-mail to Pooja demanding a medical certificate of Randeep and Arunoday with whom she was scheduled to shoot lovemaking sequences. In all fairness she also sent her own medical certificate. Basically, she wanted to make sure that she was not going to shoot with anyone who had any life threatening disease (Read HIV)."
The source explains, "Pooja Bhatt then told her that this was not the norm in Bollywood unlike for the adult films that Sunny does. The director also explained to her that she would not require to film sequences that she normally shoots for her adult films."
Finally, apparently no such medical certificate was shown to Sunny. The source states, "No one is aware what exactly happened and how Pooja convinced her." We wonder what Randeep and Arunoday had to say about this surprising demand. Pooja Bhatt remained unavailable for comment. (Mid -Day)
Porn Star Sunny Leone's Lingerie to be auctioned..
Director of 'Jism 2' Pooja Bhatt has decided to auction her lead cast's clothes, including undergarments for charity. Makers of the film lately tweeted "@Jism2 Sunny Leone's lingerie along with other clothes of her and other actors up for auction for charity... any takers?"
Porn star Sunny Leone will make her Bollywood debut with 'Jism 2'. Bollywood actors Randeep Hooda and Arunoday Singh will be seen sharing screen space with Sunny in the film. During an interview lately, Pooja Bhatt said that she is auctioning Sunny, Randeep and Arunoday’s entire wardrobe, including their underwear.Sunny Leone was chosen for the film while she came to India to participate in a popular reality show 'Bigg Boss 5'. Since then, there has been no looking back for the stunning lady.
Pooja Bhatt can't wait to release her film. Instead of August 3, 'Jism 2' will now be released on July 27, 2012. 'Jism 2', a sequel to 2003 film 'Jism', will see Sunny as seductress Izna.
The first song from Sunny Leone, Randeep Hooda and Arunoday Singh starrer 'Jism 2' is out now. As the censor board gave an 'A' rating to the video, director Pooja Bhatt decided to release it on the internet. 'Jism 2' is one of the most awaited films of 2012 as it marks the debut of porn star Sunny Leone in Bollywood.
A new song 'Maula' from 'Jism 2' starring Sunny Leone and Randeep Hooda was released on July 4 but slowly climbed up the popularity chart because of its earthy beat and lilting music.
The title song of the film 'Jism 2' is composed by Arko Pravo Mukherjee and has vocals by Ali Azmat. The lyrics are by Mukherjee and Munish Makhija.
The Pooja Bhatt film revolves around the story of an adult film star hired by a dashing intelligence officer to become a 'honey-trap' for a dreaded assassin. In doing so, she not only has to confront her bitter-sweet past, but is also forced to make an impossible choice - one that will put her own life in double jeopardy.
After teasing audiences to several steamy song promos, director Pooja Bhatt released the theatrical trailer of her much talked-about project “Jism 2” on YouTube. The clip finally showcases the international porn star Sunny Leone’s acting skills.
( images jism2.com )
In a simple blog posting today Hulu reveals that its premium Hulu Plus service has finally arrived on the Apple TV. If you're existing Hulu Plus subscriber it's simply a matter of tapping your details into the app on the Apple TV homescreen. But Hulu points out that as well as signing up via their website, you can now also create a Hulu Plus account directly through Apple's TV interface and paying via your existing iTunes account details (and an email will then tell you how to access the streaming service via other channels). A regular $7.99 fee is then charged via your iTunes account every month.
While the addition of Hulu Plus is a coup for Apple and a boon for fans of the service, at least in the regions where it's available, the iTunes pay channel is a very important part of this equation and represents an expansion of its existing Netflix pay service.
Visa Europe's 'Policy Decision' Cuts Off Mobile Phone Pay Startup iZettle
European mobile phone card payment platform iZettle has been cut off by Visa. IZettle must stop processing Visa card payments in Norway, Denmark and Finland, "based on a policy decision" by Visa Europe, iZettle said in a blog post. Visa Inc. is an investor in rival mobile card-swipe giant Square, but Visa Europe is run as an independent entity, so there is little reason to think this is a competitive move (and Square remains U.S.-centric for now). Other cards--MasterCard and American Express in Finland and Diner's Club in Denmark and Norway will continue to work with the reader. In addition to these three countries, iZettle's service is also available in Sweden (where the company is based) and the U.K.--the Swedish service is still live, which has prompted discussion over Visa's motives in quashing some of the value of the mobile card reader.
IZettle started out with an iOS app and reader, but recently started beta tests of an Android app and reader in partnership with Samsung. iZettle closed a $31.6 million funding round in mid-June from funding backers like Greylock Partners, Index Ventures and MasterCard.
Google Links Blogger With Google+, Gives Gmail Hangouts
Blogger, Google's fairly popular blogging tool just got the Google+ treatment. Now that Google's content creation and content sharing streams are hooked up, bloggers on the service can link their blogs with Google+ brand pages (blogs have been linkable to personal profiles for some time now). When new posts are ready, the Google+ integration presents the option of sharing the post as a notification to selected circles of Google+ followers. Upgrading to the Google+ feature also lets existing Google+ users add a blogger's Google+ profile to their website.
Yesterday, Google announced that Gmail and its scores of loyal users would see their video chat powered by Hangouts, a previously Google+ only group chat feature. Gmail users can video chat with contacts logged into Google+, driving a cross-talk between two of Google's services that are believed to have markedly different levels of engagement. Gmail users can play around with Hangouts feature like virtual moose ears, and group chat with up to 9 other Google users. For the full experience, however, they still need to hop over to Google+.
As the year rolls on, Google is integrating more of its existing products with its testy social network which has always had something of a engagement problem. According to a recent ComScore count Google+ user numbers had grown 66 percent since November last year to 110.7 million in June, but a previous study by RJMetrics, 30 percent of Google+ users don't post after their first time.
Google Acquires Social Ad Manager Wildfire
Companies may now manage their advertising campaigns on Facebook, Pinterest, and Twitter using a service owned by Google.
The search giant announced it had agreed to acquire social media marketing startup Wildfire in a blog post on Tuesday. Details of the acquisition weren't disclosed, though sources tell All Things D that the purchase price is around $250 million.
Wildfire helps its 16,000 customers, including Sony, Verizon and Amazon, manage social media campaigns, content and advertising across social platforms.
Companies that fit a similar social media genre have been a hot commodity lately. Oracle has agreed to acquire two such startups, Vitrue and Collective Intellect, this summer, and Salesforce agreed to buy Wildfire competitor Buddy Media for $745 million in June.
Facebook Adding Time-Shift "Save" For Later Facility To Updates
Facebook has very quietly added a new feature to its mobile apps that lets users click and hold anywhere on a status update to activate a "save" function that specially tags a long article in order that it can be accessed easily at a later moment. The function seems to act a little like the well-known Instapaper app that is handy for marking long-form web pages in order that they can be quickly accessed later in the day when a user has more time to read them, and it's also been confirmed by TheVerge.com that the new system will be coming to Facebook's main web service too. The system seems aimed squarely at user convenience, keeping a Facebook client engaged in an article found within the social network where previously it may have been left unread due to time constraints and the inconvenience of relocating the same piece of writing later in the day in someone's cluttered Timeline.
Spotify Adds Free Streaming Radio For Android Users
Spotify has given U.S. users of its Android app the ability to stream radio for free, in Pandora-like auto-curated streams based on selected tracks or playlists. The radio feature was late coming to the iOS app itself, only showing up in June, but is now accessible to a larger pool of Android users. The radio feature syncs across devices and comes with a voting feature to respond to songs that worked and those that didn't. (The desktop app made its entry in December.) Before that, mobile access to Spotify was limited to its top tier Premium members who pay $9.99 a month.
Twitter's New Clickable Stock Ticker Tags Track Tweets About Cos.
Twitter is a great streaming service for following updates from followers and lists as they happen, but has been working on its search relevance: The latest move is the addition of a clickable stock tag for companies. Clicking on "$FB" for example, will pull up a search result list for all mentions of the Facebook stock tag as well as tweets mentioning Facebook in plain English, possibly cutting through some of the noise that comes with searching via a hashtag and making it easier to keep track of the price of stock you're interested in.
The search, sort, and old tweets departments have been a bit of a weak spot for the service. In recent months Twitter has taken small steps to improve searching on its site in terms of features and effectiveness. Earlier this year, it added an autocomplete feature to throw up commn hashtags and people you follow, and started suggesting related queries and spelling corrections in listed search results.
India's central bank refuses to cut rate
India's key interest rate was left unchanged by the nation's central bank, which lowered its 2012 growth projection to 6.5% from 7.3% and raised the inflation outlook to 7%. But the bank cut the Statutory Liquidity Ratio, and leading lenders indicated their rates might come down a bit as a result. Meanwhile, India's April-June fiscal deficit was reported at 37.1% of the full fiscal year target; a year before, it was 39.4%.
Former Indian finance minister returns to post
India's new finance minister is Palaniappan Chidambaram, who moves into the new post from his job as home minister. Chidambaram has been finance minister twice before, including a stint during the 2008 crisis when he earned plaudits for his economic management.
Spain sees rising capital flight
More than 41 billion euros in capital fled Spain in May as the government struggled to back one of the country's biggest banks. From the beginning of the year through May, 163 billion euros left the country, equivalent to 16% of Spanish GDP. Separately, Spanish retail sales for June were reported down 5.2% on a seasonally adjusted basis.
German retail sales ebb even in robust job, wage environment
Despite strong wage gains and a solid job market, German retail sales were down for a third consecutive month in June, the longest run of declines since 2007. The 0.1% drop from May also came despite preliminary indications of improving consumer sentiment.
German coalition rules out euro-fund access to ECB liquidity
Proposals supported by France and Italy for permanent access by the euro rescue fund to the European Central Bank's liquidity got a cold reception in Germany, meeting outright rejection by the ruling coalition of Chancellor Angela Merkel. Characterizing such a license as a "wealth-destroying weapon," Rainer Bruederle of the Free Democratic Party said that financing debt "by means of the printing press leads to growing inflation dangers."
All eyes are on central banks, but how much more can they do?
Although markets around the world are pinning their hopes on the U.S. Federal Reserve and the European Central Bank to step up in the face of a mounting global crisis, doubts nonetheless abound about their capacity to help. "Central bankers are very conditioned to be confident in the power of monetary policy. But the markets are questioning how many arrows they have left in their quiver," said Benjamin Pace, chief U.S. investment officer for Deutsche Bank Private Wealth Management.
U.S. home prices, business activity take upward paths
Seasonally adjusted U.S. home prices were up for the fourth consecutive month in May, and an index of business activity for July was positive as well, with both measures suggesting bright spots in the U.S. economy. On the fiscal side, however, the Treasury Department said the government expects to borrow $592 billion for the second half of the year in the midst of only modest economic growth.
Market Activities
INTERNATIONAL MARKETS OVERVIEW
Poorer-than-expected results from UBS and BP weighed on European stocks Tuesday, as did new indications that Germany might thwart action by the European Central Bank to address the euro crisis. The Stoxx Europe 600 index ended down 1%. On Wall Street, the S&P 500 Index edged 0.43% lower as investors awaited some indication from the U.S. Federal Reserve. Here is a continuously updated list of global stock indexes.
Economic Trends & Outlook
Japan posts better jobs numbers, but outlook remains clouded
Despite lagging exports and a buoyant yen, Japan's unemployment rate declined in July to 4.3%, down one notch from June's 4.4%. Gains, however, were concentrated in the service sector while manufacturing employment was down, portending uncertainty in coming months as the euro crisis plays out.
Taiwan, South Korea indicators all point downward
Taiwan's gross domestic product edged back 0.16% in the second quarter as the country's consumer confidence index fell in June. Meanwhile, South Korea reported a decline in output. In combination with an earlier reported slide in Japanese manufacturing, the indicators all pointed to a need for further stimulus across Asia.
With local lending mandate and rail push, China looks to lift economy
Chinese private banks have been ordered to step up lending to local governments, apparently part of Chinese leaders' broader plan to stimulate the economy. The push comes as the Ministry of Railways boosts investment 16% in another sector of the country's infrastructure. Separately, foreign exchange regulators said China's capital and financial account pivoted to a deficit of $71.4 billion in the second quarter from a surplus in the preceding period.
Thailand exports decline 2% in first half
Thailand's exports were off 2.0% for the first half of the year, contributing to a slower Thai economy in June. Lingering problems in the eurozone contributed to the lower figures, and the Finance Ministry said it would dial back its export target in September as a result.
Thailand moves aggressively to seize business opportunities in region
Thailand is looking to bounce back strongly from the 2008 global financial meltdown and the country's devastating floods last year as its businesses seek out developing consumer markets in neighboring countries. The drive has included more than $20 billion of investment in the region, taking advantage of buying opportunities generated by the crisis. For all that, Thailand faces stiff competition and hurdles, including "the challenge ... to move up the value chain and not get stuck on low-value-added jobs," says Hozefa Topiwalla, head of research for Southeast Asia at Morgan Stanley in Singapore.
Capital Markets & Financial Products
Shaky markets are cited as 2 Asia-focused funds close
Volatile markets and wary investors are being cited as Lazard closes its South Korean-focused activist hedge fund and China International Capital Corp. pulls the curtain on its Asian long/short equity fund. The Lazard fund made its debut in 2006 and invested in small to midsize South Korean businesses with a nod to social responsibility.
China central bank's reverse repo raises speculation on reserves cut
Raising speculation that a cut in the reserve requirement ratios for banks may be in store, China's central bank Tuesday injected 8 billion yuan into the market in a seven-day reverse repo. "Liquidity conditions at the end of July are apparently better than those in end-June. ... In the light of the current situation, the size of central bank's [potential] reverse repos would directly determine liquidity conditions in financial institutions," a trader with a state-owned commercial bank was quoted as saying.
Malaysia launches Kuala Lumpur financial site
A major financial hub "that can grow both Islamic and conventional finance" was the hope as Malaysian Prime Minister Najib Razak opened a 70-acre financial district in Kuala Lumpur. The government expects 250 global companies to locate at the Tun Razak Exchange site.
4 firms launch fund for Philippine infrastructure
Four investment firms are launching a $625 million fund targeted for infrastructure deals in the Philippines. "We aim to finance five to 10 investments with approximately $50 million to $125 million for each project. The fund should be fully deployed within the next three years and, given the robust pipeline in the Philippines, we are confident we can deploy it well," said Frank Kwok, senior managing director of Macquarie Infrastructure and Real Assets Asia, the fund manager.
Ethics & Standards
Guilty plea is entered in insider trading case against ex-Hanlong exec
Guilty plea is entered in insider trading case against ex-Hanlong exec
A former vice president for Hanlong Mining has pleaded guilty to serial insider trading that dates from 2006. Calvin Bo Shi Zhu's plea comes with a decision pending from China's National Development and Reform Commission on Hanlong's proposed takeover of Australian miner Sundance Resources.
• Arena Pharmaceuticals, Inc. (ARNA) Transfers Diet Pill Application to Eisai Company, Ltd. (ESALY.PK) More...
• FDA Accepts NuPathe Inc. (PATH)'s Migraine Patch NDA Resubmission for Filing More...
• Ariad Pharmaceuticals, Inc. (ARIA) Announces Submission of New Drug Application for Ponatinib to the FDA More...
• Vertex Pharmaceuticals Incorporated (VRTX) Lowers Incivek View; New Drug Data Lifts Shares More...
• Nymox Pharmaceutical (NYMX) Reports Positive Results From Combined Statistical Analysis of Long Term Follow-Up Studies of BPH Drug More...
• Rockwell Medical Technologies (RMTI) Completes Patient Enrollment in Phase III Clinical Trials for SFP Iron-Delivery in Hemodialysis Patients More...
• Pfizer Inc. (PFE) Announces Positive Top-Line Results From the ORAL Start Phase 3 Study of Tofacitinib in Rheumatoid Arthritis More...
• FDA Requests Teleconference to Discuss Repros Therapeutics Inc. (RPRX) Phase 2 Protocol for Proellex® in the Treatment of Endometriosis Last Week of August More...
• Mindreading Hormone? A Better Judge of Character With Nasal Spray? University of Oslo Study More...
• Rejected Alzheimer's Drug Shows New Potential, Mount Sinai School of Medicine Study More...
• Brains are Different in People With Highly Superior Autobiographical Memory,University of California, Irvine Study More...
• Computer Scientists Present Smile Database, University of Amsterdam Study More...
• Brain Development Delayed in ADHD, National Institutes of Health (NIH) Study More...
• StemCells Inc. (STEM) Broadens HuCNS-SC® Patent Portfolio With Key Patent in Japan More...
• GeNO LLC Receives Two Additional Patents For Inhaled Nitric Oxide Drug Delivery More...
• Abon Announces CLOLAR® Patent Challenge More...
• GlaxoSmithKline (GSK) Shipping U.S. Flu Vaccine With New Strain Coverage Recommended for 2012-2013 More...
• Mersana Therapeutics, Inc. Raises $27 Million to Advance Antibody-drug Conjugates More...
• Ultragenyx Raises $15 Million Toward $30 Million Goal More...
• CytomX Therapeutics, Inc. Expands Series B Financing; Canaan PartnersJoins Syndicate More...
• CMC Biologics Acquires XOMA Corporation (XOMA)'s Bay Area Manufacturing Facility More...
• CytoDyn Announces Entry into Agreement With Progenics Pharmaceuticals, Inc. (PGNX) to Acquire PRO 140 More...
• Idenix Pharmaceuticals, Inc. (IDIX) Regains Drug Rights From Partner Novartis AG (NVS) More...
• PolyMedix Inc. (PYMX.OB) and University of Pennsylvania Collaborate to Develop New Class of Defensin-Mimetic Antimicrobial Compounds to Treat Malaria More...
• Furiex Pharmaceuticals, Inc. (FURX) Announces Closing of Priligy® Asset Transfer and License Agreements More...
• Oncobiologics Inc. Announces a Collaboration Agreement with XOMA Corporation (XOMA) to Utilize XOMA's Fully Human Antibody Libraries for Their Discovery Platform More...
• Anchor Therapeutics Enters Into Collaborative Research Agreement With Kyowa Hakko Kirin for its Pepducin Technology More...
• KV Pharmaceutical CEO Gets Hefty Raise, Despite All the Problems More...
• Soren Tulstrup to Lead Shire plc (SHPG) HGT's MPS Franchise More...
• Cytovance Biologics Inc. Announces Don Wuchterl as Senior Vice President of Manufacturing Operations More...
• Quick-Med Technologies (QMDT) Appoints Bernd Liesenfeld as President More...
• A.P. Pharma, Inc. (APPA) Appoints Robert Rosen to Its Board of Directors More...
• Bayer AG (BAY.F) Lifts Guidance, Provisions Weigh on Earnings More...
• Acura Pharmaceuticals, Inc. (ACUR) Announces Second Quarter 2012 Financial Results More...
• Agennix AG Reports Financial Results for Second Quarter and First Half of 2012 More...
• Amarin Corporation PLC (AMRN) to Report Second Quarter 2012 Financial Results and Host Conference Call on August 8, 2012 More...
• Acasti Pharma First Quarter Results More...
• Teva Pharmaceutical Industries Limited (TEVA) Sues Genzyme Corporation (GENZ) for Poaching Employees More...
• EU Antitrust Charge for Servier, Teva Pharmaceutical Industries Limited (TEVA), Others Over Generics More...
• Immunovative Inc. Announces the Retention of Winston & Strawn LLP as Its Legal Counsel More...
• Vitrolife's Subsidiary in the USA has Been Sued More...
